{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:19:08Z","timestamp":1790929148413,"version":"4.1.0"},"reference-count":26,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"unspecified","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011933","name":"Chongqing Science and Technology Foundation","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-MSX0486"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0486"]}],"id":[{"id":"10.13039\/501100011933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJZD-K202400407"],"award-info":[{"award-number":["KJZD-K202400407"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,2,7]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe diagnostic framework classification, treatment patterns and outcomes in Kawasaki disease-associated macrophage activation syndrome (KD-MAS) using a single-centre cohort and a structured descriptive synthesis of published cases to inform hypothesis generation and future refinement of diagnostic and management strategies for KD-MAS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective single-centre cohort study. MAS was classified by haemophagocytic lymphohistiocytosis (HLH)-2004, HLH-2009 or 2016 systemic juvenile idiopathic arthritis (sJIA)-MAS criteria. Data were abstracted around a prespecified MAS window; severity was indexed by haemophagocytic syndrome diagnostic score (HScore) and the association between HScore and treatment escalation was assessed using Firth\u2019s logistic regression. In parallel, we conducted a literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In our centre, incidence was 0.6% (22\/3786); mean age was 3.72 years; coronary involvement was 77.2%. The proportions of clinician-diagnosed KD-MAS cases fulfilling each framework were HLH-2004 14\/22, HLH-2009 18\/22 and 2016 sJIA-MAS 20\/22; 11 met all three. Cytopenias, liver dysfunction and coagulopathy were frequent; management followed stepwise escalation from intravenous immunoglobulin (IVIG) or corticosteroid monotherapy to IVIG plus corticosteroids and, when required, to adjunct immunosuppressive\/biologic therapy; similar patterns appeared in the literature. HScore was higher with intensified therapy than with standard therapy (median 274 vs 199; p=0.020). Each 10-point HScore increase was associated with higher odds of escalation (OR 1.44 univariable; 1.37 adjusted).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The 2016 sJIA-MAS criteria demonstrate the highest proportion fulfilling criteria in our cohort for KD-MAS. Treatment in our cohort and in published cases generally reflected a stepwise, typically progressing from IVIG\u00b1glucocorticoids\u2009to adjunct immunosuppressants\/biologics. Higher HScores co-occurred with escalation, suggesting they capture baseline severity; prospective multicentre studies are needed to test incremental value and risk-stratification thresholds.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2025-006524","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:40:26Z","timestamp":1773067226000},"page":"e006524","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["2016 sJIA-MAS criteria and a step-up therapeutic approach in KD-MAS: insights from a combined cohort and literature review"],"prefix":"10.1136","volume":"12","author":[{"given":"Yuanhao","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"},{"name":"Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"},{"name":"Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9656-0296","authenticated-orcid":false,"given":"Xuemei","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"},{"name":"Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"},{"name":"Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9664-4473","authenticated-orcid":false,"given":"Xi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China"},{"name":"Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026030907401415000_12.1.e006524.1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1053\/j.jvca.2025.02.007","article-title":"Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association","volume":"39","author":"Houska","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2026030907401415000_12.1.e006524.2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.33549\/physiolres.934672","article-title":"Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome","volume":"71","author":"Bordea","year":"2022","journal-title":"Physiol Res"},{"key":"2026030907401415000_12.1.e006524.3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2019.03.001","article-title":"Cytokine profile of macrophage activation syndrome associated with Kawasaki disease","volume":"119","author":"Jinkawa","year":"2019","journal-title":"Cytokine"},{"key":"2026030907401415000_12.1.e006524.4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/pai.13158","article-title":"Macrophage activation syndrome in pediatrics","volume":"31 Suppl 24","author":"Alongi","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"2026030907401415000_12.1.e006524.5","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1058159"},{"key":"2026030907401415000_12.1.e006524.6","article-title":"Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment","volume":"11","author":"Lee","year":"2024","journal-title":"Children (Basel)"},{"key":"2026030907401415000_12.1.e006524.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.07.007"},{"key":"2026030907401415000_12.1.e006524.8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12519-020-00360-6","article-title":"Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches","volume":"16","author":"Han","year":"2020","journal-title":"World J Pediatr"},{"key":"2026030907401415000_12.1.e006524.9","doi-asserted-by":"crossref","unstructured":"Choi U-Y , Han S-B , Lee S-Y , et al . Should refractory Kawasaki disease be considered occult macrophage activation syndrome? Semin Arthritis Rheum 2017;46. doi:10.1016\/j.semarthrit.2016.08.007","DOI":"10.1016\/j.semarthrit.2016.08.007"},{"key":"2026030907401415000_12.1.e006524.10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039"},{"key":"2026030907401415000_12.1.e006524.11","doi-asserted-by":"crossref","unstructured":"Filipovich AH . Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009;127\u201331. doi:10.1182\/asheducation-2009.1.127","DOI":"10.1182\/asheducation-2009.1.127"},{"key":"2026030907401415000_12.1.e006524.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208982"},{"key":"2026030907401415000_12.1.e006524.13","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026030907401415000_12.1.e006524.14","unstructured":"R Core Team . R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2024. Available: https:\/\/www.R-project.org\/"},{"key":"2026030907401415000_12.1.e006524.15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-229708","article-title":"High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant","volume":"12","author":"Lind-Holst","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2026030907401415000_12.1.e006524.16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.arcped.2017.04.017","article-title":"Syndrome d\u2019activation macrophagique et maladie de Kawasaki: \u00e0 propos de quatre observations [Macrophage activation syndrome and Kawasaki disease: Four new cases]","volume":"24","author":"Dumont","year":"2017","journal-title":"Archives de P\u00e9diatrie"},{"key":"2026030907401415000_12.1.e006524.17","article-title":"Hemophagocytic lymphohistiocytosis prior to the diagnosis of Kawasaki disease","volume":"52","author":"Ogawa","year":"2015","journal-title":"Indian Pediatr"},{"key":"2026030907401415000_12.1.e006524.18","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00423","article-title":"Kawasaki Disease Complicated With Macrophage Activation Syndrome: Case Reports and Literature Review","volume":"7","author":"Jin","year":"2019","journal-title":"Front Pediatr"},{"key":"2026030907401415000_12.1.e006524.19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5152\/balkanmedj.2016.150371","article-title":"Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl","volume":"33","author":"Do\u011fan","year":"2016","journal-title":"Balkan Med J"},{"key":"2026030907401415000_12.1.e006524.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30651-4"},{"key":"2026030907401415000_12.1.e006524.21","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062101","article-title":"Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 Pandemic","volume":"152","author":"Molloy","year":"2023","journal-title":"Pediatrics"},{"key":"2026030907401415000_12.1.e006524.22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147076","article-title":"Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C","volume":"131","author":"Zhu","year":"2021","journal-title":"J Clin Invest"},{"key":"2026030907401415000_12.1.e006524.23","article-title":"Macrophage Activation Syndrome in Kawasaki Disease: Insights from a Systematic Literature Review on Diagnosis, Clinical Features, and Treatment","volume":"12","author":"Inguscio","year":"2025","journal-title":"Children (Basel)"},{"key":"2026030907401415000_12.1.e006524.24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/rheumatology\/keae391","article-title":"Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project","volume":"64","author":"Baldo","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026030907401415000_12.1.e006524.25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121233"},{"key":"2026030907401415000_12.1.e006524.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.03.017"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2025-006524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:40:29Z","timestamp":1773067229000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2025-006524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/rmdopen-2025-006524"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2025-006524","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}